Similarly, both MFN2 and PGC-1α were down-regulated in pulmonary arterial smooth muscle cells (PASMC) in two different experimental models of PAH, and in patients with PAH while MFN2 reversed this phenotype. The gene discussed is PPARGC1A; the disease is pulmonary arterial hypertension.